ECSP099077A - Formas polimórficas y proceso - Google Patents

Formas polimórficas y proceso

Info

Publication number
ECSP099077A
ECSP099077A EC2009009077A ECSP099077A ECSP099077A EC SP099077 A ECSP099077 A EC SP099077A EC 2009009077 A EC2009009077 A EC 2009009077A EC SP099077 A ECSP099077 A EC SP099077A EC SP099077 A ECSP099077 A EC SP099077A
Authority
EC
Ecuador
Prior art keywords
polymorphic forms
cancer
formula
preparation
treatment
Prior art date
Application number
EC2009009077A
Other languages
English (en)
Inventor
Kai Schiemann
Ulrich Emde
Tobias Schlueter
Christoph Saal
Michael Maiwald
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ECSP099077A publication Critical patent/ECSP099077A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a un proceso para la preparación de compuestos enantioméricamente enriquecidos o puros de la fórmula I en donde R1, R2, R3, R6, R7 y Q se definen como en la reivindicación 1, así como sus formas cristalinas para el tratamiento de enfermedades proliferativas como el cáncer.
EC2009009077A 2006-06-19 2009-01-16 Formas polimórficas y proceso ECSP099077A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06012525 2006-06-19

Publications (1)

Publication Number Publication Date
ECSP099077A true ECSP099077A (es) 2009-02-27

Family

ID=38687475

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009077A ECSP099077A (es) 2006-06-19 2009-01-16 Formas polimórficas y proceso

Country Status (19)

Country Link
US (1) US8198452B2 (es)
EP (1) EP2032581B1 (es)
JP (1) JP5322928B2 (es)
KR (1) KR20090020702A (es)
CN (1) CN101472928A (es)
AR (1) AR061379A1 (es)
AU (1) AU2007263393B2 (es)
BR (1) BRPI0712393A2 (es)
CA (1) CA2656064C (es)
EA (1) EA015994B1 (es)
EC (1) ECSP099077A (es)
ES (1) ES2537759T3 (es)
IL (1) IL195844A0 (es)
MX (1) MX2008016071A (es)
NZ (1) NZ574236A (es)
PE (1) PE20080337A1 (es)
TW (1) TW200815453A (es)
WO (1) WO2007147480A2 (es)
ZA (1) ZA200900383B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005027170A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Substituierte Tetrahydrochinoline
DE102007021862A1 (de) * 2007-05-10 2008-11-13 Merck Patent Gmbh Wässrige pharmazeutische Zubereitung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3345355A1 (de) * 1983-12-15 1985-06-27 Hoechst Ag, 6230 Frankfurt Verfahren zur racematspaltung bicyclischer imino-(alpha)-carbonsaeureester
DE4203547A1 (de) * 1992-02-07 1993-08-12 Knoll Ag Verfahren zur racemattrennung von verapamil
JPH07247286A (ja) * 1994-01-18 1995-09-26 Sankyo Co Ltd 含窒素環状化合物の光学分割方法
JPH07330732A (ja) * 1994-06-10 1995-12-19 Kyorin Pharmaceut Co Ltd 光学活性な３−アミノ−１−ベンジルピペリジン誘導体
GB0010437D0 (en) * 2000-04-28 2000-06-14 Darwin Discovery Ltd Process
US20040002615A1 (en) * 2002-06-28 2004-01-01 Allen David Robert Preparation of chiral amino-nitriles
EP1761515B1 (de) * 2003-12-20 2008-11-05 MERCK PATENT GmbH 2-(hetero-)aryl substituierte tetrahydrochinolinderivate

Also Published As

Publication number Publication date
ES2537759T3 (es) 2015-06-11
AU2007263393B2 (en) 2012-03-01
JP5322928B2 (ja) 2013-10-23
CA2656064C (en) 2013-11-05
IL195844A0 (en) 2009-09-01
PE20080337A1 (es) 2008-04-25
AR061379A1 (es) 2008-08-20
US20090176820A1 (en) 2009-07-09
EA200802400A1 (ru) 2009-06-30
WO2007147480A3 (en) 2008-05-08
EP2032581B1 (en) 2015-03-11
TW200815453A (en) 2008-04-01
KR20090020702A (ko) 2009-02-26
CN101472928A (zh) 2009-07-01
MX2008016071A (es) 2009-01-15
CA2656064A1 (en) 2007-12-27
JP2009541231A (ja) 2009-11-26
AU2007263393A1 (en) 2007-12-27
EA015994B1 (ru) 2012-01-30
EP2032581A2 (en) 2009-03-11
NZ574236A (en) 2010-11-26
ZA200900383B (en) 2010-01-27
US8198452B2 (en) 2012-06-12
WO2007147480A2 (en) 2007-12-27
BRPI0712393A2 (pt) 2012-10-16

Similar Documents

Publication Publication Date Title
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
PA8809001A1 (es) Compuestos organicos
PA8819201A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
ECSP099818A (es) Procesos para la preparacion de pirazoles
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
CL2008000670A1 (es) Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras.
UY31026A1 (es) Derivados de sulfonil amida para el tratamiento del crecimiento celular anormal
CY1111702T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
ECSP109921A (es) Sulfonamidas como moduladores de trpm8
CO6300954A2 (es) Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk
CL2009000990A1 (es) Uso de epotilona d para el tratamiento de enfermedades asociadas a tau, tal como enfermedad alzheimer, parkinson, entre otras.
CY1116436T1 (el) Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης
UY32859A (es) Compuestos y composiciones como inhibidores de cinasa de proteina
DOP2010000302A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
DOP2009000287A (es) Oxazolidinonas sustituidas y su uso
UY28333A1 (es) Inhibidores de caspasa y sus usos.
CR11452A (es) 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios
PA8855001A1 (es) Monocarbamas
CO6382123A2 (es) Antagonistas de la via hedgehog de ftalazina disustituida
ECSP11010867A (es) Compuestos novedosos de fenilamino-isonicotinamida
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
DOP2006000061A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
ATE527248T1 (de) Polymorphe von enantioreinem erdostein